← back to search

Zhao Yuan

Qinghai University · CN
🔎 Find collaborators in Cancer Research · Molecular Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Natural product bioactivities and synthesis, and Cancer-related molecular mechanisms research.
h-index
13
citations
505
works
41
NIH funding
primary concept
email

Recent publications

Proteomics of plasma-derived extracellular vesicles reveals S100A8 as a novel biomarker for Alzheimer's disease: A preliminary study
Journal of Proteomics 2024cited by 18position: middledoi
PFOS Exposure Promotes Hepatotoxicity in Quails by Exacerbating Oxidative Stress and Inflammation-Induced Apoptosis through Activating TLR4/MyD88/NF-κb Signaling
ACS Omega 2024cited by 11position: middledoi
Long intergenic non-coding RNA DIO3OS promotes osteosarcoma metastasis via activation of the TGF-β signaling pathway: a potential diagnostic and immunotherapeutic target for osteosarcoma
Cancer Cell International 2023cited by 9position: middledoi
Resveratrol reverses <scp>TGF</scp>‐β1‐mediated invasion and metastasis of breast cancer cells via the <scp>SIRT3</scp>/<scp>AMPK</scp>/autophagy signal axis
Phytotherapy Research 2022cited by 43position: middledoi
Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis
npj Precision Oncology 2021cited by 35position: middledoi
Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma
Frontiers in Immunology 2021cited by 17position: middledoi
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA
EBioMedicine 2020cited by 46position: middledoi
Abstract A21: Longitudinal analysis of cell-free DNA for therapy monitoring of ALK-positive non-small cell lung cancer
Clinical Cancer Research 2020cited by 0position: middledoi
Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in <i>KLC1–ALK</i>-rearranged lung cancer
Molecular Case Studies 2019cited by 23position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael Meister · Heidelberg University4 papers (2019–2021)Matthias Schlesner · University of Augsburg4 papers (2019–2021)Marc A. Schneider · Heidelberg University4 papers (2019–2021)Steffen Dietz · Deutschen Konsortium für Translationale Krebsforschung4 papers (2019–2021)Michael Thomas · Barwon Health4 papers (2019–2021)Petros Christopoulos · Torbay Hospital4 papers (2019–2021)Holger Sültmann · German Cancer Research Center4 papers (2019–2021)Albrecht Stenzinger · Chirurgische Universitätsklinik Heidelberg4 papers (2019–2021)Simon J. Ogrodnik · German Cancer Research Center4 papers (2019–2021)Lisa Gu · Southwestern Medical Center3 papers (2019–2020)Tomasz Żemojtel · Berlin Institute of Health at Charité - Universitätsmedizin Berlin3 papers (2019–2020)Martin Reck · St. Luke's Clinic3 papers (2019–2020)Volker Endris · Deutschen Konsortium für Translationale Krebsforschung3 papers (2019–2020)Anna‐Lena Volckmar · Heidelberg University3 papers (2019–2020)Thomas Muley · Heidelberg University3 papers (2019–2020)Xigao Cheng · Nanchang University2 papers (2021–2023)Jia Guo · Tongji University2 papers (2021–2023)Jingyu Jia · Nanchang University2 papers (2021–2023)Tianlong Wu · Nanchang University2 papers (2021–2023)Florian Janke · German Cancer Research Center2 papers (2020–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Molecular Biology →